DBV Technologies S.A. - American Depositary Shares (DBVT)
14.09
-1.12 (-7.36%)
NASDAQ · Last Trade: Oct 30th, 8:57 PM EDT
Detailed Quote
Previous Close
15.21
Open
14.65
Bid
7.230
Ask
17.62
Day's Range
14.04 - 15.06
52 Week Range
0.4409 - 18.00
Volume
49,874
Market Cap
776.31M
PE Ratio (TTM)
-17.40
EPS (TTM)
-0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
191,524
Chart
About DBV Technologies S.A. - American Depositary Shares (DBVT)
Dbv Technologies is a biopharmaceutical company focused on developing innovative therapies for patients with food allergies, particularly peanut allergies. Utilizing its proprietary Systemic Immunotherapy platform, the company aims to create treatments that help desensitize individuals to allergens, ultimately enhancing their quality of life and reducing the risk of severe allergic reactions. By leveraging advanced medical technology and a rigorous clinical development approach, Dbv Technologies strives to bring novel, breakthrough solutions to the field of immunotherapy for food allergies. Read More
